Incidence of ovarian cancer after bilateral salpingo-oophorectomy in women with histologically proven endometriosis
Observational
OA: bronze
CC0
⤵ 7 in-corpus citations
AI-generated summary
This study investigated the incidence of ovarian cancer in women who underwent bilateral salpingo-oophorectomy for histologically confirmed endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To assess the incidence of ovarian cancer in women with histologically proven endometriosis after bilateral salpingo-oophorectomy (BSO).
DESIGN: Retrospective nationwide cohort study.
SETTING: Dutch pathology database.
PATIENT(S): Women with histologically proven endometriosis who had undergone BSO between 1990 and 2015 (n = 7,984). This study consists of 2 control cohorts: women with histologically proven endometriosis without BSO (n = 42,633) and women with a benign dermal nevus (n = 132,535).
INTERVENTION(S): Observational study.
MAIN OUTCOME MEASURE(S): Number of histologic diagnoses of (extra-)ovarian cancers. Incidence rate ratios (IRR) were estimated for (extra-)ovarian cancer. The number needed to treat was calculated.
RESULT(S): We identified 9 (0.1%) (extra-)ovarian cancers in the BSO cohort and 170 (0.4%) and 444 (0.3%) ovarian cancers in the endometriosis and nevus control cohorts, respectively. We found an age-adjusted IRR of 0.34 (95% confidence interval [CI], 0.15-0.76) when the BSO cohort was compared with the endometriosis cohort. Comparing the BSO cohort with the nevus control cohort resulted in an age-adjusted IRR of 0.38 (95% CI, 0.17-0.85). The number needed to treat when the BSO cohort was compared with the endometriosis control cohort was 351 (95% CI, 272-591).
CONCLUSION(S): In this nationwide study, we found that the (extra-)ovarian cancer incidence in women with histologically proven endometriosis decreased to less than the background population risk after BSO. Additionally, we found a significant reduction of the incidence of ovarian cancer when compared with women with histologically proven endometriosis without BSO. Endometriosis surgery could in the future be a preventive strategy in women with endometriosis and a high-risk profile for ovarian cancer.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (20)
- Endometriosis and cancer: a systematic review and meta-analysis via openalex
- Epidemiology of endometriosis: a large population-based database study from a healthcare provider with 2 million members via openalex
- Hormonal and surgical treatments for endometriosis and risk of epithelial ovarian cancer via openalex
- Immunologic factors involved in the malignant transformation of endometriosis to endometriosis-associated ovarian carcinoma via openalex
- Incidence of endometrioid and clear-cell ovarian cancer in histological proven endometriosis: the ENOCA population-based cohort study via openalex
- Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors via openalex
- Increased incidence of ovarian cancer in both endometriosis and adenomyosis via openalex
- Risk factors of epithelial ovarian carcinomas among women with endometriosis: a systematic review via openalex
- Risk of Gynecologic Cancer According to the Type of Endometriosis via openalex
- W6603743216 via openalex
- W1982900907 via openalex
- W6747063688 via openalex
- W2119913499 via openalex
- W2404782822 via openalex
- W2780553007 via openalex
- W2807649309 via openalex
- W2889646458 via openalex
- W2909791732 via openalex
- W2966505635 via openalex
- W3162975920 via openalex
Cited by (8)
- Guideline No. 468: Clinical Management of Endometriosis 2026
- Lignes directrices de pratique clinique n° 468 : Prise en charge clinique de l'endométriose 2026
- The Occurrence and Histopathological Recognition of Atypical Endometriosis in Patients with Ovarian Endometriosis – a Retrospective Cohort Study 2025
- The occurrence and histopathological recognition of atypical endometriosis in patients with ovarian endometriosis - a retrospective cohort study 2025
- The Optimal Age for Oophorectomy in Women with Benign Conditions: A Narrative Review 2025
- Endometriosis as a risk factor for ovarian cancer: an update on screening, risk reduction, treatment and prognosis 2024
- DRUG THERAPIES IN THE TREATMENT OF ENDOMETRIOSIS 2023
- Endometriosis: not just a benign disease 2022
Source provenance
- europepmc
- last seen: 2026-10-22T06:08:12.857683+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:34:23.551347+00:00
License: CC0
· commercial use OK